DOJ at­tor­ney says Boehringer In­gel­heim has 'tremen­dous lever­age' in IRA ne­go­ti­a­tions

Drug­mak­ers have lever­age and are get­ting “a re­al ne­go­ti­a­tion” with the gov­ern­ment over the prices of prod­ucts se­lect­ed un­der the In­fla­tion Re­duc­tion Act, a DOJ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER